News
7d
MedPage Today on MSNFecal Transplant Noninferior to Vancomycin for Initial C. Diff TherapyFecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...
The addition of vancomycin to beta-lactam prophylaxis in ... trial product was purchased removed the commercial labels and placed a sheath over the vial. Placebo consisted of matching empty ...
Daptomycin is a lipopeptide with bactericidal activity that acts on the cell membrane of enterococci and is often used off-label to treat patients infected with vancomycin-resistant enterococci.
"Vancomycin has been our last-ditch antibiotic ... Instead it has contracted with Danish drugmaker Xellia to make them with a Civica Rx label. Civica Rx's member health systems currently include ...
Study: Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures.
Vancomycin flushing syndrome (VFS) is a reaction to the antibiotic vancomycin. Symptoms include flushing and itching, among others. VFS was previously known as “red man syndrome.” However, the ...
Vancomycin always has been a problematic agent for treating patients with Staphylococcus infections because of its poor tissue penetration and slow bactericidal activity. In recent years, its use ...
Vancomycin could offer new therapeutic option for patients with a type of inflammatory bowel disease
Results published in the Journal of Crohn's and Colitis revealed that an antibiotic called vancomycin may also be effective in treating people who have a specific type of inflammatory bowel ...
Staphylococcus aureus has the potential to develop durable vancomycin resistance, according to a new study. Staphylococcus aureus has the potential to develop durable vancomycin resistance ...
Vancomycin is the drug of choice for treating cellulitis, study suggests. ScienceDaily . Retrieved June 3, 2025 from www.sciencedaily.com / releases / 2010 / 10 / 101024122348.htm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results